Tendai Chiware, MD, a reproductive endocrinologist and director of third party reproduction at Brooklyns Genesis Fertility, part of the Pinnacle Fertility network
Challenges Hindering GLP-1 Nutritional Support Growth Despite the growing demand, the industry faces challenges related to gastrointestinal side effects, which affect up to 50% of GLP-1 users
Intermediate values were observed for liraglutide (11 days, IQR 257), tirzepatide (19 days, IQR 369), lixisenatide (20 days, IQR 5116), and semaglutide (27 days, IQR 577) (Table S6)
The scale is only one marker
The standard starting dose is 20 units on an insulin syringe (0.2 mL)
We expect huge evolutions in that platform and expansion of offerings there that patients really do love and are having great outcomes